Pharmaceutical Marketing

Pharmaceutical and medical device companies face regulatory requirements around social media content that most industries never encounter, from FDA fair-balance rules to MLR review workflows and pharmacovigilance obligations. This tag covers how regulated life sciences companies can safely use content automation for low-risk categories like corporate news and investor updates, while keeping branded product and clinical content behind a proper pre-publish compliance gate. Start here if you're building or auditing a compliant social media distribution process for a regulated organization. The usable split is between corporate and investor content, which automates cleanly, and anything naming a product, which does not. Reviewing once at the source is what makes the rest safe to leave running.